Volume : 10, Issue : 03, March – 2023
Title:
34.THE ROLE OF ECHOCARDIOGRAPHY IN HEART FAILURE
Authors :
Aditi Das
Abstract :
Heart failure (HF) is a serious medical condition characterized by high mortality and morbidity rates, poor functional capacity, and reduced quality of life. It affects more than 64 million people globally and has become a significant public health concern due to its high economic and social burden. To address this challenge, echocardiography has emerged as a critical diagnostic and therapeutic tool in the evaluation and management of HF patients.
Echocardiography offers numerous advantages over other imaging modalities, including its non-invasive nature, ease of availability, and safety. It allows clinicians to obtain a comprehensive assessment of cardiac structure and function, including ventricular size, shape, and function. Echocardiography also plays a crucial role in risk stratification and the initial phenotype assessment of HF patients, providing essential data for guiding therapeutic decision-making and monitoring treatment efficacy.
Advances in echocardiography have expanded its applications in HF patient care, enabling more accurate assessment of systolic and diastolic function. This includes the use of novel echocardiographic techniques such as strain imaging, speckle tracking, and 3D echocardiography, which allow clinicians to evaluate ventricular deformation, regional wall motion abnormalities, and global cardiac function.
Moreover, RV evaluation is increasingly being recognized as a critical component of echocardiographic assessment in HF patients. RV dysfunction is prevalent in HF patients, and its assessment can provide important prognostic information and guide management decisions. Echocardiography provides a safe and practical means of assessing RV function, including RV size, shape, and systolic function.
In summary, echocardiography is an indispensable tool in the evaluation and management of HF patients. It allows for a comprehensive assessment of cardiac structure and function, risk stratification, and therapeutic decision-making. With advances in echocardiographic techniques, clinicians can obtain vital data on systolic and diastolic function, including RV evaluation, improving patient outcomes and reducing the economic and social burden of HF.
Keywords: Systolic dysfunction, Diastolic dysfunction, Ejection fraction, Heart failure, Echocardiography.
Cite This Article:
Please cite this article in press Aditi Das, The Role Of Echocardiography In Heart Failure, Indo Am. J. P. Sci, 2023; 10 (03).
Number of Downloads : 10
References:
1. Jaski, B. E. (2010). The 4 Stages of Heart Failure. In B. E. Jaski (Ed.), Managing Advanced Heart Failure: A Clinician’s Guide (pp. 287-347). New York: Demos Medical. ISBN: 978-1-935395-30-0.
2. Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G., Coats, A. J., … van der Meer, P. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 18, 891-975.
3. Pocock, S. J., Ariti, C. A., McMurray, J. J., Maggioni, A., Køber, L., Squire, I. B., … Doughty, R. N. (2013). Predicting survival in heart failure: A risk score based on 39,372 patients from 30 studies. European Heart Journal, 34, 1404-1413.
4. Butler, J., Fonarow, G. C., Zile, M. R., Lam, C. S., Roessig, L., Schelbert, E. B., … Gheorghiade, M. (2014). Developing therapies for heart failure with preserved ejection fraction: Current state and future directions. JACC Heart Failure, 2, 97-112.
5. Löfman, I., Szummer, K., Dahlström, U., Jernberg, T., & Lund, L. H. (2017). Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction. European Journal of Heart Failure, 19, 1606-1614.
6. Chioncel, O., Lainscak, M., Seferovic, P. M., Anker, S. D., Crespo-Leiro, M. G., Harjola, V. P., … Filippatos, G. (2017). Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: An analysis of the ESC Heart Failure Long-Term Registry. European Journal of Heart Failure, 19, 1574-1585.
7. Vedin O, Lam CSP, Koh AS, Benson L, Teng THK, Tay WT, Braun OÖ, Savarese G, Dahlström U, Lund LH. (2017). Significance of ischemic heart disease in patients with heart failure and preserved, midrange, and reduced ejection fraction: a nationwide cohort study. Circulation: Heart Failure, 10, e003875.
8. Rastogi, A., Novak, E., Platts, A. E., & Mann, D. L. (2017). Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction. European Journal of Heart Failure, 19(12), 1597-1605. doi: 10.1002/ejhf.952
9. Mele D, Campana M, Sclavo M, Seveso G, Aschieri D, Nesta F, D’Aiello I, Ferrari R, Levine RA. Impact of tissue harmonic imaging in patients with distorted left ventricles: improvement in accuracy and reproducibility of visual, manual and automated echocardiographic assessment of left ventricular ejection fraction. Eur J Echocardiogr 2003;4:59–67.
10. Tei, C., Nishimura, R. A., Seward, J. B., Tajik, A. J., & editors. (1995). New index of combined systolic and diastolic myocardial performance: A simple and reproducible measure of cardiac function- a study in normal and dilated cardiomyopathy. Journal of Cardiology, 26(6), 357-366.
11. Armstrong, W. F., & Ryan, T. (2010). Evaluation of left ventricular diastolic dysfunction. In W. F. Armstrong & T. Ryan (Eds.), Feigenbaum’s echocardiography (7th ed., pp. 175-179). Philadelphia: Lippincott Williams & Wilkins.
12. Kotecha, T., Knight, D. S., Razvi, Y., Kumar, K., Vimalesvaran, K., Thornton, G., … & Moon, J. C. (2021). Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. European Heart Journal, 42(19), 1866-1878. doi: 10.1093/eurheartj/ehab075.
13. Puntmann, V. O., Carerj, M. L., Wieters, I., Fahim, M., Arendt, C., Hoffmann, J., … & Zeiher, A. M. (2020). Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA cardiology, 5(11), 1265-1273. doi:10.1001/jamacardio.2020.3557.
14. Wibowo A, Pranata R, Astuti A, Tiksnadi BB, Martanto E, Martha JW, Purnomowati A, Rizki Akbar M. Left and right ventricular longitudinal strains are associated with poor outcome in COVID-19: a systematic review and meta-analysis. J Intensive Care. 2021;9:9. doi:10.1186/s40560-020-00519-3.
15. Jotsol Pinto, A., & George Koshy. (2021). Role of Echocardiography in Heart Failure Today. Current Cardiology Reports, 23(5), 45. doi: 10.1007/s11886-021-01463-x. PMID: 33742357.
16. Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., et al. (2015). Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, 28(1), 1-39. doi: 10.1016/j.echo.2014.10.003.
17. Kumar, V., Sharma, R., & Dagar, K. S. (2014). L wave in echo Doppler. Indian Heart Journal, 66(3), 392-393.
18. Omar AMS, Bansal M, Sengupta PP. Advances in Echocardiographic Imaging in Heart Failure with Reduced and Preserved Ejection Fraction. Circ Res 2016; 119:357-74. doi: 10.1161/CIRCRESAHA.116.308075.
19. Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., … & Evangelista, A. (2009). Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Journal of the American Society of Echocardiography, 22(2), 107-133.
20. Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation. 2018 Aug 28;138(9):861-870. doi: 10.1161/CIRCULATIONAHA.118.033712. PMID: 30354420.
21. Tao Y, Wu J, Zhang H, et al. H2FPEF score predicts 1-year rehospitalization of patients with heart failure with preserved ejection fraction. Postgrad Med J. 2021;97(1145):164-167. doi: 10.1136/postgradmedj-2019-137464.
22. Suzuki, S., Yamamoto, T., Tokuda, N., Suzuki, K., Suzuki, H., & Hosokawa, K. et al. (2020). H2 FPEF score for predicting future heart failure in stable outpatients with cardiovascular risk factors. ESC Heart Failure, 7(1), 65-74. doi: 10.1002/ehf2.12581.
23. Lam, C. S. P., Roger, V. L., Rodeheffer, R. J., Borlaug, B. A., Enders, F. T., & Redfeld, M. M. (2009). Pulmonary hypertension in heart failure with preserved ejection fraction: A community-based study. Journal of the American College of Cardiology, 53, 1119-1126.
24. Kirkpatrick, J. N., Vannan, M. A., Narula, J., & Lang, R. M. (2007). Echocardiography in heart failure: applications, utility, and new horizons. Journal of the American College of Cardiology, 50, 381–396.
25. Priori, S., Blomstrom-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., Kirchhof, P., Kjeldsen, K., Kuck, K. H., Hernandez-Madrid, A., Nikolaou, N., Norekvål, T. M., Spaulding, C., & Van Veldhuisen, D. J. (2015). 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). European Heart Journal, 36, 2793–2867. doi: 10.1093/eurheartj/ehv316
26. Arbustini E, Narula N, Dec GW, et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol. 2013;62:2046–2072.
27. Thavendiranathan, P., Liu, S., Verhaert, D., Calleja, A., Nitinunu, A., Van Houten, T., … Ryan, T. (2012). Feasibility, accuracy, and reproducibility of real-time full-volume 3D transthoracic echocardiography to measure LV volumes and systolic function: a fully automated endocardial contouring algorithm in sinus rhythm and atrial fibrillation. JACC Cardiovascular Imaging, 5(3), 239-251. doi: 10.1016/j.jcmg.2011.11.014.
28. Tei, C., Nishimura, R. A., Seward, J. B., & Tajik, A. J. (1997). Non-invasive Doppler-derived myocardial performance index: Correlation with simultaneous measurements of cardiac catheterization measurements. Journal of the American Society of Echocardiography, 10, 169-178.
29. Tsang TS, Barnes ME, Bailey KR, Leibson CL, Montgomery SC, Takemoto Y, Diamond PM, Marra MA, Gersh BJ, Wiebers DO, Petty GW, Seward JB. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc. 2001;76:467–475.
30. Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., … & Ruschitzka, F. (2016). 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 18(8), 891-975.
31. Wang, T. J. (2003). Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation, 108, 977-982.
32. Cheesman, M. G., Leech, G., Chambers, J., Monaghan, M. J., & Nihoyannopoulos, P. (1998). Central role of echocardiography in the diagnosis and assessment of heart failure. Heart, 80(Suppl 2), S1-S5.
33. Metra, M., & Teerlink, J. R. (2017). Heart failure. Lancet, 390, 1981-1995.
34. Wong, C. Y., O’Moore-Sullivan, T., Leano, R., Byrne, N., Beller, E., & Marwick, T. H. (2004). Alterations of left ventricular myocardial characteristics associated with obesity. Circulation, 110(19), 3081-3087.
35. Shah, A. M., Claggett, B., Sweitzer, N. K., Shah, S. J., Anand, I. S., Liu, L., … & Pitt, B. (2015). Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone. Circulation, 132(5), 402-414.
36. Hung, C. L., Verma, A., Uno, H., Shin, S. H., Bourgoun, M., Hassanein, A. H., … & Solomon, S. D. (2010). Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction. Journal of the American College of Cardiology, 56(22), 1812-1822.
37. Narayanan, A., Aurigemma, G. P., Chinali, M., Hill, J. C., Meyer, T. E., & Tighe, D. A. (2009). Cardiac mechanics in mild hypertensive heart disease: a speckle-strain imaging study. Circulation: Cardiovascular Imaging, 2(5), 382-390.
38. Lam, C. S. P., Roger, V. L., Rodeheffer, R. J., Borlaug, B. A., Enders, F. T., & Redfeld, M. M. (2009). Pulmonary hypertension in heart failure with preserved ejection fraction: A community-based study. Journal of the American College of Cardiology, 53, 1119-1126.
39. Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., … & Popescu, B. A. (2016). Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, 29(4), 277-314.
40. Singbal, Y., Vollbon, W., Huynh, L. T., Wang, W. Y., Ng, A. C., & Wahi, S. (2015). Exploring noninvasive tricuspid dp/dt as a marker of right ventricular function. Echocardiography, 32(9), 1347-1351.